Sangamo Therapeutics, Inc financial data

Symbol
SGMO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
501 Canal Blvd., Richmond, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
SANGAMO BIOSCIENCES INC (to 1/6/2017)
Latest financial report
10-K - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % -57%
Debt-to-equity 206 % +345%
Return On Equity -40.4 % +10.5%
Return On Assets -90.1 % -0.51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 225M shares +25.6%
Common Stock, Shares, Outstanding 213M shares +19.5%
Entity Public Float 74.2M USD -67.6%
Common Stock, Value, Issued 2.13M USD +19.5%
Weighted Average Number of Shares Outstanding, Basic 202M shares +15.6%
Weighted Average Number of Shares Outstanding, Diluted 202M shares +15.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 57.8M USD -67.2%
Research and Development Expense 112M USD -52.4%
General and Administrative Expense 44.7M USD -26.9%
Operating Income (Loss) -104M USD +62.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -98.1M USD +62.7%
Income Tax Expense (Benefit) -167K USD +96.7%
Net Income (Loss) Attributable to Parent -97.9M USD +62%
Earnings Per Share, Basic -0.49 USD/shares +66.9%
Earnings Per Share, Diluted -0.49 USD/shares +66.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 41.9M USD -7.27%
Cash, Cash Equivalents, and Short-term Investments 81M USD -73.7%
Accounts Receivable, after Allowance for Credit Loss, Current 526K USD -43%
Assets, Current 51.7M USD -45.2%
Property, Plant and Equipment, Net 17.9M USD -33.4%
Operating Lease, Right-of-Use Asset 16.9M USD -35.1%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 0 USD
Other Assets, Noncurrent 879K USD -30.5%
Assets 102M USD -38.5%
Accounts Payable, Current 15.5M USD +1.48%
Accrued Liabilities, Current 8.2M USD -65.2%
Contract with Customer, Liability, Current 7.56M USD
Liabilities, Current 45.8M USD -4.04%
Contract with Customer, Liability, Noncurrent 5.87M USD
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 26.3M USD -21.7%
Other Liabilities, Noncurrent 933K USD -21.4%
Liabilities 78.9M USD -4.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.53M USD -63.9%
Retained Earnings (Accumulated Deficit) -1.5B USD -6.96%
Stockholders' Equity Attributable to Parent 22.8M USD -72.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 82.9M USD -71.9%
Liabilities and Equity 102M USD -38.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.7M USD +26.6%
Net Cash Provided by (Used in) Financing Activities 22.1M USD +176%
Net Cash Provided by (Used in) Investing Activities 35.8M USD +0.31%
Common Stock, Shares Authorized 960M shares 0%
Common Stock, Shares, Issued 213M shares +19.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 43.4M USD -7.04%
Deferred Tax Assets, Valuation Allowance 368M USD +4.6%
Deferred Tax Assets, Gross 371M USD +3.94%
Operating Lease, Liability 30.6M USD -19.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -101M USD +60.3%
Lessee, Operating Lease, Liability, to be Paid 37M USD -18.2%
Property, Plant and Equipment, Gross 57.7M USD -25.9%
Operating Lease, Liability, Current 4.31M USD -6.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.37M USD -2.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.71M USD -1.74%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +35.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.21M USD -9.77%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.32M USD -2.91%
Deferred Tax Assets, Operating Loss Carryforwards 212M USD +7.56%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 22.1M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.5M USD +0.15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.41M USD -59.7%
Deferred Tax Assets, Net of Valuation Allowance 3.68M USD -36.2%
Share-based Payment Arrangement, Expense 12.4M USD -54.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%